首页 > 最新文献

Medecine tropicale et sante internationale最新文献

英文 中文
[Identification of tick-borne borreliosis cases by qPCR from rapid malaria diagnostic tests during the Grand Magal of Touba in Senegal]. [在塞内加尔图巴大Magal期间通过快速疟疾诊断检测qPCR鉴定蜱传borreliosis病例]。
Pub Date : 2025-08-16 eCollection Date: 2025-12-31 DOI: 10.48327/mtsi.v5i4.2025.732
Coumba Diouf, Ihssane Ouaddane, Georges Diatta, Mamadou Lamine Bara Goumbala, Abdourahmane Sow, Déguène Fam, Mbayang Faye, Philippe Gautret, Cheikh Sokhna

Introduction: Antigen rapid diagnostic tests (RDTs) have been developed to facilitate malaria diagnosis in endemic areas. The blood samples collected for these tests can also be used to diagnose other infections.

Methods: We performed nucleic acid extraction followed by PCR identification of dengue virus (DENV), Borrelia spp., Bartonella spp., and Coxiella burnetti on RDTs collected from different health facilities in Touba during the Grand Magal of Touba (GMT), a mass gathering known for its infectious disease risks.

Results: A total of 2,381 RDTs were collected from eight healthcare facilities in the Mbacke department in 2022 and 2023 during the GMT. Thirteen cases (0.5%) of tick-borne relapsing fever borreliosis were identified by quantitative PCR (qPCR), including two cases of malaria-borreliosis co-infection. None of the samples tested positive for DENV, Bartonella spp., or C. burnetti.

Conclusion: Our results confirm that RDT antigens can diagnose non-malaria fevers, such as borreliosis, in some GMT participants with fever. Malaria RDTs used in the field are an easily accessible source of clinical samples for studying the epidemiology of fevers of unknown origin in GMT contexts.

抗原快速诊断试验(rdt)的发展是为了促进疟疾流行地区的诊断。为这些测试收集的血液样本也可用于诊断其他感染。方法:我们对在图巴大Magal (GMT)期间从图巴不同卫生机构收集的rrt进行了核酸提取和PCR鉴定,并对登革病毒(DENV)、伯氏疏螺旋体、巴尔通体和伯氏考克氏体进行了核酸提取。结果:在2022年和2023年格林尼治标准时间期间,从mbackke部门的8家医疗机构共收集了2,381例RDTs。采用定量PCR (qPCR)检测到13例(0.5%)蜱传回归热borreliosis,其中2例为疟疾-borreliosis合并感染。所有样本均未检测出登革热病毒、巴尔通体或伯内蒂囊胞菌阳性。结论:我们的研究结果证实,RDT抗原可以诊断非疟疾发烧,如borreliosis,在一些GMT参与者发烧。现场使用的疟疾快速诊断试验是一种易于获得的临床样本来源,可用于研究格林尼治标准时间背景下不明原因发热的流行病学。
{"title":"[Identification of tick-borne borreliosis cases by qPCR from rapid malaria diagnostic tests during the Grand Magal of Touba in Senegal].","authors":"Coumba Diouf, Ihssane Ouaddane, Georges Diatta, Mamadou Lamine Bara Goumbala, Abdourahmane Sow, Déguène Fam, Mbayang Faye, Philippe Gautret, Cheikh Sokhna","doi":"10.48327/mtsi.v5i4.2025.732","DOIUrl":"10.48327/mtsi.v5i4.2025.732","url":null,"abstract":"<p><strong>Introduction: </strong>Antigen rapid diagnostic tests (RDTs) have been developed to facilitate malaria diagnosis in endemic areas. The blood samples collected for these tests can also be used to diagnose other infections.</p><p><strong>Methods: </strong>We performed nucleic acid extraction followed by PCR identification of dengue virus (DENV), <i>Borrelia</i> spp., <i>Bartonella</i> spp., and <i>Coxiella burnetti</i> on RDTs collected from different health facilities in Touba during the Grand Magal of Touba (GMT), a mass gathering known for its infectious disease risks.</p><p><strong>Results: </strong>A total of 2,381 RDTs were collected from eight healthcare facilities in the Mbacke department in 2022 and 2023 during the GMT. Thirteen cases (0.5%) of tick-borne relapsing fever borreliosis were identified by quantitative PCR (qPCR), including two cases of malaria-borreliosis co-infection. None of the samples tested positive for DENV, <i>Bartonella</i> spp., or <i>C. burnetti.</i></p><p><strong>Conclusion: </strong>Our results confirm that RDT antigens can diagnose non-malaria fevers, such as borreliosis, in some GMT participants with fever. Malaria RDTs used in the field are an easily accessible source of clinical samples for studying the epidemiology of fevers of unknown origin in GMT contexts.</p>","PeriodicalId":101416,"journal":{"name":"Medecine tropicale et sante internationale","volume":"5 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12948369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147329058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Tibial aplasia. Treatment by tibialization of the fibula and compensation for shortening by holding the foot in equinus position in Bangui, Central African Republic]. (胫骨发育不全。在中非共和国班吉,通过腓骨胫骨固定和通过将脚保持在马蹄形位置来补偿缩短的治疗]。
Pub Date : 2025-08-07 eCollection Date: 2025-12-31 DOI: 10.48327/mtsi.v5i4.2025.655
Michel Onimus, Anselme Yafondo

Objective: Congenital absence of the tibia (congenital tibial aplasia) causes significant disability when walking. The usual treatment, which involves lengthening the lower leg or early amputation followed by prosthetic fitting, requires technical resources that are often lacking in developing countries. The proposed alternative consists of tibialization of the fibula with limb lengthening and by preservation of the foot equinismus.

Patients and method: The records of 25 children with congenital tibial aplasia were reviewed. Ten of these children underwent tibialization of the fibula (operated between one and three years of age) and amputation (at six and eight years of age) in two cases.

Results: With a mean follow-up period of two years and seven months, correct alignment of the lower leg and foot below the knee was achieved in all cases of tibialization of the fibula. Two children achieved independent walking. Three children were lost for follow-up.

Discussion: The management of congenital tibial aplasia must consider the local socioeconomic context. Although the follow-up period in this study is short, the protocol is simple and well-accepted by families.

Conclusion: Conservative treatment of tibial aplasia through tibialization of the fibula with equinus preservation to compensate the shortening is simple and takes local socioeconomic constraints into account, while avoiding the limitations and costs of modern protocols. Furthermore, it is always well accepted by families.

目的:先天性胫骨缺失(先天性胫骨发育不全)导致行走时明显的残疾。通常的治疗方法包括延长小腿长度或早期截肢,然后安装假肢,这需要发展中国家往往缺乏的技术资源。建议的替代方案包括腓骨胫骨固定和肢体延长,并保留足跖。患者与方法:回顾性分析25例先天性胫骨发育不全患儿的临床资料。其中10名儿童接受了腓骨胫骨固定(在1至3岁之间进行手术)和截肢(在6至8岁)。结果:在平均2年零7个月的随访期间,所有腓骨胫骨固定的病例都实现了小腿和脚在膝盖以下的正确对齐。两个孩子实现了独立行走。3名儿童失联随访。讨论:先天性胫骨发育不全的治疗必须考虑当地的社会经济背景。虽然本研究随访时间较短,但方案简单,为家庭所接受。结论:保守治疗胫骨发育不全,采用腓骨固定加马蹄骨保留补偿缩短的方法简单,考虑了当地的社会经济约束,同时避免了现代治疗方案的局限性和成本。此外,它总是被家庭所接受。
{"title":"[Tibial aplasia. Treatment by tibialization of the fibula and compensation for shortening by holding the foot in equinus position in Bangui, Central African Republic].","authors":"Michel Onimus, Anselme Yafondo","doi":"10.48327/mtsi.v5i4.2025.655","DOIUrl":"10.48327/mtsi.v5i4.2025.655","url":null,"abstract":"<p><strong>Objective: </strong>Congenital absence of the tibia (congenital tibial aplasia) causes significant disability when walking. The usual treatment, which involves lengthening the lower leg or early amputation followed by prosthetic fitting, requires technical resources that are often lacking in developing countries. The proposed alternative consists of tibialization of the fibula with limb lengthening and by preservation of the foot equinismus.</p><p><strong>Patients and method: </strong>The records of 25 children with congenital tibial aplasia were reviewed. Ten of these children underwent tibialization of the fibula (operated between one and three years of age) and amputation (at six and eight years of age) in two cases.</p><p><strong>Results: </strong>With a mean follow-up period of two years and seven months, correct alignment of the lower leg and foot below the knee was achieved in all cases of tibialization of the fibula. Two children achieved independent walking. Three children were lost for follow-up.</p><p><strong>Discussion: </strong>The management of congenital tibial aplasia must consider the local socioeconomic context. Although the follow-up period in this study is short, the protocol is simple and well-accepted by families.</p><p><strong>Conclusion: </strong>Conservative treatment of tibial aplasia through tibialization of the fibula with equinus preservation to compensate the shortening is simple and takes local socioeconomic constraints into account, while avoiding the limitations and costs of modern protocols. Furthermore, it is always well accepted by families.</p>","PeriodicalId":101416,"journal":{"name":"Medecine tropicale et sante internationale","volume":"5 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12948360/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147328713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[PASS units: mechanisms for delivering healthcare to underserved populations. The example of the Hôtel-Dieu PASS, Paris]. [PASS单位:向服务不足的人口提供保健的机制。以Hôtel-Dieu PASS为例,Paris]。
Pub Date : 2025-08-06 eCollection Date: 2025-12-31 DOI: 10.48327/mtsi.v5i4.2025.729
Alexandra Rehbinder, Hélène de Champs-Léger, Louis Crozier, Guillaume Rieutord, Hélène Lelong

The 1998 French law on combating exclusion established PASS units (Permanences d'Accès aux Soins de Santé, or Healthcare Access Points) to guarantee access to healthcare for all, including people in precarious situations. PASS centers aim to address the social, economic, administrative, and linguistic barriers that prevent vulnerable populations from accessing the healthcare system.This article provides an overview of how PASS operate in France and describes the PASS at Hôtel-Dieu in Paris (Public Hospitals of Paris). This PASS offers patients a holistic approach that includes medical care, psychiatric follow-up, social support, interpretation services, and specialized consultations.As of 2023, there were 451 PASS centers in France. The Hôtel-Dieu PASS, with its multidisciplinary team, carried out over 10,500 medical consultations for 4,144 patients. Most users are young male migrants without health insurance (69%) or stable housing (nearly 90%). The most common conditions are chronic diseases (e.g., hypertension and diabetes), infectious diseases (e.g., hepatitis B/C, HIV, and tuberculosis), and mental health issues (e.g., post-traumatic stress disorder and anxiety).The Hôtel-Dieu example illustrates the specific features of PASS centers: accessibility without appointments, single locations and time slots, and adaptability to precarious schedules. These services enable vulnerable populations to reconnect with the healthcare system. However, their effectiveness depends on long-term funding, enhanced medical and social coordination, and institutional recognition of their role.PASS units respond to an ethical and public health imperative: caring for those furthest from the healthcare system. Their sustainability requires adequate human and financial resources. They must remain places of innovation, welcome, and inclusion that constantly adapt to social, political, and migratory changes.

1998年法国关于打击排斥现象的法律设立了医疗保健接入点(PASS),以保证所有人,包括处境危险的人都能获得医疗保健。PASS中心旨在解决社会、经济、行政和语言障碍,这些障碍阻碍弱势群体进入医疗保健系统。本文概述了PASS在法国的运作方式,并介绍了巴黎(巴黎公立医院)Hôtel-Dieu的PASS。该PASS为患者提供全面的方法,包括医疗护理、精神病学随访、社会支持、口译服务和专业咨询。截至2023年,法国共有451个PASS中心。Hôtel-Dieu PASS及其多学科小组为4 144名患者进行了10 500多次医疗咨询。大多数使用者是没有医疗保险(69%)或稳定住房(近90%)的年轻男性移民。最常见的情况是慢性病(如高血压和糖尿病)、传染病(如乙型/丙型肝炎、艾滋病毒和结核病)和精神健康问题(如创伤后应激障碍和焦虑)。Hôtel-Dieu示例说明了PASS中心的具体特性:无需预约的可访问性、单一的位置和时间段,以及对不稳定时间表的适应性。这些服务使弱势群体能够重新获得卫生保健系统。然而,其有效性取决于长期供资、加强医疗和社会协调以及机构对其作用的认识。PASS单位响应道德和公共卫生的要求:照顾那些远离医疗保健系统的人。它们的可持续性需要足够的人力和财政资源。它们必须始终是创新、欢迎和包容的地方,不断适应社会、政治和移民的变化。
{"title":"[PASS units: mechanisms for delivering healthcare to underserved populations. The example of the Hôtel-Dieu PASS, Paris].","authors":"Alexandra Rehbinder, Hélène de Champs-Léger, Louis Crozier, Guillaume Rieutord, Hélène Lelong","doi":"10.48327/mtsi.v5i4.2025.729","DOIUrl":"10.48327/mtsi.v5i4.2025.729","url":null,"abstract":"<p><p>The 1998 French law on combating exclusion established PASS units (Permanences d'Accès aux Soins de Santé, or Healthcare Access Points) to guarantee access to healthcare for all, including people in precarious situations. PASS centers aim to address the social, economic, administrative, and linguistic barriers that prevent vulnerable populations from accessing the healthcare system.This article provides an overview of how PASS operate in France and describes the PASS at Hôtel-Dieu in Paris (Public Hospitals of Paris). This PASS offers patients a holistic approach that includes medical care, psychiatric follow-up, social support, interpretation services, and specialized consultations.As of 2023, there were 451 PASS centers in France. The Hôtel-Dieu PASS, with its multidisciplinary team, carried out over 10,500 medical consultations for 4,144 patients. Most users are young male migrants without health insurance (69%) or stable housing (nearly 90%). The most common conditions are chronic diseases (e.g., hypertension and diabetes), infectious diseases (e.g., hepatitis B/C, HIV, and tuberculosis), and mental health issues (e.g., post-traumatic stress disorder and anxiety).The Hôtel-Dieu example illustrates the specific features of PASS centers: accessibility without appointments, single locations and time slots, and adaptability to precarious schedules. These services enable vulnerable populations to reconnect with the healthcare system. However, their effectiveness depends on long-term funding, enhanced medical and social coordination, and institutional recognition of their role.PASS units respond to an ethical and public health imperative: caring for those furthest from the healthcare system. Their sustainability requires adequate human and financial resources. They must remain places of innovation, welcome, and inclusion that constantly adapt to social, political, and migratory changes.</p>","PeriodicalId":101416,"journal":{"name":"Medecine tropicale et sante internationale","volume":"5 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12948364/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147329061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Post-stroke epilepsy: First data from Niger]. 卒中后癫痫:来自尼日尔的首个数据。
Pub Date : 2025-07-06 eCollection Date: 2025-12-31 DOI: 10.48327/mtsi.v5i4.2025.654
Zakaria Mamadou, Fawzia Abdoulaye Dara, Moussa Toudou Daouda, Inoussa Daouda Bako, Amadou Abdou Bacharou, Fataoulaye Soumana Hassane, Éric Adehossi

Introduction: Post-stroke epilepsy is defined as unprovoked seizures occurring in a person with a history of stroke after all other causes have been excluded.

Objective: This study aimed to determine the epidemiological, clinical, radiological, and evolutionary characteristics of post-stroke epilepsy in the neurology department of the general referral hospital in Niamey, Niger. The study was retrospective, descriptive, and analytical, and it was conducted over a period of 29 months. Results. A total of 4,765 patients were included in the study, 21 of whom were diagnosed with post-stroke epilepsy. This represents a hospital prevalence of 4.4%o. The sex ratio was 0.75. The average age was 64. Ischemic stroke (IS) was the most common type, accounting for 81% of cases, with lesions most often occurring in the superficial territory of the middle cerebral artery. Seizures were focal in 52.4% of cases and occurred late, within one to two years. Most patients were treated with monotherapy, primarily with carbamazepine.

Conclusion: The outcome was favorable in 71.5% of cases with appropriate treatment.

卒中后癫痫定义为卒中史患者在排除所有其他原因后发生的非诱发性癫痫发作。目的:本研究旨在确定尼日尔尼亚美综合转诊医院神经科卒中后癫痫的流行病学、临床、放射学和进化特征。本研究为回顾性、描述性和分析性研究,持续时间为29个月。结果。共有4765名患者参与了这项研究,其中21人被诊断为中风后癫痫。这表明医院的患病率为4.4%。性别比为0.75。平均年龄为64岁。缺血性中风(IS)是最常见的类型,占81%的病例,病变多发生在大脑中动脉的浅表区域。52.4%的病例为局灶性发作,发作时间较晚,为1 ~ 2年。大多数患者接受单药治疗,主要是卡马西平。结论:经适当治疗,71.5%的患者预后良好。
{"title":"[Post-stroke epilepsy: First data from Niger].","authors":"Zakaria Mamadou, Fawzia Abdoulaye Dara, Moussa Toudou Daouda, Inoussa Daouda Bako, Amadou Abdou Bacharou, Fataoulaye Soumana Hassane, Éric Adehossi","doi":"10.48327/mtsi.v5i4.2025.654","DOIUrl":"10.48327/mtsi.v5i4.2025.654","url":null,"abstract":"<p><strong>Introduction: </strong>Post-stroke epilepsy is defined as unprovoked seizures occurring in a person with a history of stroke after all other causes have been excluded.</p><p><strong>Objective: </strong>This study aimed to determine the epidemiological, clinical, radiological, and evolutionary characteristics of post-stroke epilepsy in the neurology department of the general referral hospital in Niamey, Niger. The study was retrospective, descriptive, and analytical, and it was conducted over a period of 29 months. Results. A total of 4,765 patients were included in the study, 21 of whom were diagnosed with post-stroke epilepsy. This represents a hospital prevalence of 4.4%o. The sex ratio was 0.75. The average age was 64. Ischemic stroke (IS) was the most common type, accounting for 81% of cases, with lesions most often occurring in the superficial territory of the middle cerebral artery. Seizures were focal in 52.4% of cases and occurred late, within one to two years. Most patients were treated with monotherapy, primarily with carbamazepine.</p><p><strong>Conclusion: </strong>The outcome was favorable in 71.5% of cases with appropriate treatment.</p>","PeriodicalId":101416,"journal":{"name":"Medecine tropicale et sante internationale","volume":"5 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12948368/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147329071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[OverView of infectious and non-infectious diseases in French Polynesia in 2025]. [2025年法属波利尼西亚传染病和非传染病概况]。
Pub Date : 2025-07-03 DOI: 10.48327/mtsi.v5i3.2025.714
Erwan Oehler, Rémi Mayan, Stéphane Lastère, Jean-Marc Ségalin, Bertrand Remaudière, Lam Nguyen, Jérôme Debacre, Bertrand Condat, Van-Mai Cao-Lormeau, Hervé Bossin, Clémence Gatti Howell, Marine Jullien, Sébastien Nunez, Ronan Delaval, Raphaël Buon, Rainui Richaud, Éric Parrat, Stéphane Sauget, Pierre Gustin, Shari-Lane Botche, Philippe Genet, Johan Sebti, Moerani Rereao, Loïc Durand, Philippe Dupire, Jean-François Butaud, Cristel Thomas, Loïc Epelboin

Tahiti or the "myth of Paradise", Bora Bora, "the Pearl of the Pacific". Who has never wanted to take a plane and come and land on the heavenly beaches of Polynesia, a French territory at the antipodes of mainland France lost in the middle of the Pacific? However, we do not imagine that 60% of Polynesians live below the metropolitan low-income threshold or that life expectancy is lower than that of the mainland due to the high prevalence of cardiovascular diseases with three quarters overweight population.In addition to non-transmissible metabolic diseases, various pathologies common to temperate countries present specificities in Polynesia, leading to sometimes different management and medical reasoning. Indeed, in Polynesia where the islands extend over an area of the size of Europe, delays in treatment are frequent and it can sometimes seem difficult to send sick patients back to their isolated island. Certain pathologies that were once common in France, such as acute rheumatic fever, are still prevalent there, while others, such as gout, are rarely seen elsewhere in terms of prevalence or severity. Even if the geographical distance has protected Polynesia from a number of tropical diseases including malaria or dangerous animals, this territory presents a range of varied infectious diseases including arboviruses, leptospirosis, tuberculosis and leprosy or angiostrongylosis. Skin infections are very common with their corollary of complications including endocarditis and osteoarticular infections. The sea, which is omnipresent, also poses certain dangers such as ciguatera poisoning and exposure to certain marine organisms.Care is provided according to current medical standards thanks to European-level resources allowing diagnostic and therapeutic possibilities that do not exist in other Pacific island states.The objective of this overview is to guide health care providers coming to or practicing in French Polynesia in their daily practice, but also practitioners taking care of people returning from Polynesia.

塔希提岛或“天堂神话”,波拉波拉岛,“太平洋明珠”。谁从来没有想过乘坐飞机来到波利尼西亚的天堂般的海滩上降落呢?波利尼西亚是法国的领土,位于法国大陆的对跖点,消失在太平洋中央。然而,我们没有想到,60%的波利尼西亚人生活在大都市低收入门槛以下,或者预期寿命低于大陆,因为心血管疾病的高患病率和四分之三的超重人口。除了非传染性代谢性疾病外,温带国家常见的各种病症在波利尼西亚也具有特殊性,导致有时采取不同的管理和医学推理。事实上,在波利尼西亚,这些岛屿的面积与欧洲相当,治疗延误经常发生,有时似乎很难将病人送回他们的孤岛。某些曾经在法国很常见的疾病,如急性风湿热,在法国仍然很流行,而另一些疾病,如痛风,在其他地方的流行程度或严重程度都很少见。尽管地理距离使波利尼西亚免受包括疟疾或危险动物在内的一些热带疾病的侵害,但该领土存在一系列不同的传染病,包括虫媒病毒、钩端螺旋体病、结核病和麻风病或血管线虫病。皮肤感染是非常常见的并发症,包括心内膜炎和骨关节感染。无所不在的海洋也会带来某些危险,例如雪卡毒素中毒和接触某些海洋生物。由于欧洲一级的资源提供了其他太平洋岛屿国家所不具备的诊断和治疗可能性,因此按照现行的医疗标准提供了护理。概述的目的是指导前往法属波利尼西亚或在法属波利尼西亚执业的卫生保健提供者的日常执业,以及照顾从波利尼西亚返回的人的从业人员。
{"title":"[OverView of infectious and non-infectious diseases in French Polynesia in 2025].","authors":"Erwan Oehler, Rémi Mayan, Stéphane Lastère, Jean-Marc Ségalin, Bertrand Remaudière, Lam Nguyen, Jérôme Debacre, Bertrand Condat, Van-Mai Cao-Lormeau, Hervé Bossin, Clémence Gatti Howell, Marine Jullien, Sébastien Nunez, Ronan Delaval, Raphaël Buon, Rainui Richaud, Éric Parrat, Stéphane Sauget, Pierre Gustin, Shari-Lane Botche, Philippe Genet, Johan Sebti, Moerani Rereao, Loïc Durand, Philippe Dupire, Jean-François Butaud, Cristel Thomas, Loïc Epelboin","doi":"10.48327/mtsi.v5i3.2025.714","DOIUrl":"10.48327/mtsi.v5i3.2025.714","url":null,"abstract":"<p><p>Tahiti or the \"myth of Paradise\", Bora Bora, \"the Pearl of the Pacific\". Who has never wanted to take a plane and come and land on the heavenly beaches of Polynesia, a French territory at the antipodes of mainland France lost in the middle of the Pacific? However, we do not imagine that 60% of Polynesians live below the metropolitan low-income threshold or that life expectancy is lower than that of the mainland due to the high prevalence of cardiovascular diseases with three quarters overweight population.In addition to non-transmissible metabolic diseases, various pathologies common to temperate countries present specificities in Polynesia, leading to sometimes different management and medical reasoning. Indeed, in Polynesia where the islands extend over an area of the size of Europe, delays in treatment are frequent and it can sometimes seem difficult to send sick patients back to their isolated island. Certain pathologies that were once common in France, such as acute rheumatic fever, are still prevalent there, while others, such as gout, are rarely seen elsewhere in terms of prevalence or severity. Even if the geographical distance has protected Polynesia from a number of tropical diseases including malaria or dangerous animals, this territory presents a range of varied infectious diseases including arboviruses, leptospirosis, tuberculosis and leprosy or angiostrongylosis. Skin infections are very common with their corollary of complications including endocarditis and osteoarticular infections. The sea, which is omnipresent, also poses certain dangers such as ciguatera poisoning and exposure to certain marine organisms.Care is provided according to current medical standards thanks to European-level resources allowing diagnostic and therapeutic possibilities that do not exist in other Pacific island states.The objective of this overview is to guide health care providers coming to or practicing in French Polynesia in their daily practice, but also practitioners taking care of people returning from Polynesia.</p>","PeriodicalId":101416,"journal":{"name":"Medecine tropicale et sante internationale","volume":"5 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12416339/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145031556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Current status of antiretroviral treatment for people living with human immunodeficiency virus in Burkina Faso in the era of the World Health Organization's "test and treat" strategy]. [在世界卫生组织实施“检测和治疗”战略的时代,布基纳法索人体免疫缺陷病毒感染者抗逆转录病毒治疗的现状]。
Pub Date : 2025-06-25 DOI: 10.48327/mtsi.v5i2.2025.631
Wedminère Noélie Zoungrana-Yameogo, Christian Yonli, Toussaint Compaore, Fidèle Bakiono, Arielle Rita Belem, Luc Delma, Abdoulaye So, Ouo Mireille Coulibaly, Koiné Maxime Drabo

Introduction: The World Health Organization's (WHO) "test and treat" strategy has significantly increased the number of people living with HIV (PLHIV) who receive antiretroviral therapy (ART). This study aimed to evaluate the status of ART in Burkina Faso during this period.

Methods: A retrospective descriptive study was conducted in Plateau-Central, one of the country's 13 regions. We extracted annual data from 2018 to 2023 from the pharmaceutical dispensing database, which is used to monitor individuals receiving ART. We analyzed a trend in treatment initiation. Quantitative variables were described using the median and interquartile range, and qualitative variables were described using proportions.

Results: From 2018 to 2023, the proportion of people who started treatment each year compared to the number of people who tested positive increased from 25% to 100%. Among adults during this period, more than 70% were women. The median age at the start of treatment ranged from 35 years (28-44) to 32 years (25-44). The median treatment duration ranged from five years [2-8] to six years [3-12]. The proportion of adults with at least 95% ART dispensing coverage fluctuated, ranging from a maximum of 70% in 2020 to a minimum of 47% in 2023. The main treatment combination used in adults was TDF/FTC/EFV, accounting for 42% in 2018, 50% in 2019, and 38% in 2020. The TDF/3TC/EFV combination was dominant in 2021, accounting for 46%. In 2022 and 2023, the TDF/3TC/DTG combination was the most common, at 76% in 2022 and 91% in 2023. Among children, males were predominant (around 55%) from 2019 to 2022. The median age at treatmentinitiation ranged from two years [0-9] to four years [2-9], and the median treatment duration ranged from five years [2-8] to six years [3-12]. AZT/3TC/NVP was predominant from 2018 to 2021 (57%, 59%, 40%, and 40%), and ABC/3TC/DTG was predominant from 2022 (52% and 84%). From 2018 to 2023, the proportion of children with at least 95% ART dispensing coverage fluctuated, ranging from a maximum of 76% in 2019 to a minimum of 24% in 2023.

Conclusion: The proportion of people on ART has gradually increased since the WHO's "test and treat" recommendations. These results bring Burkina Faso closer to achieving the UNAIDS targets.

简介:世界卫生组织(WHO)“检测和治疗”战略显著增加了接受抗逆转录病毒治疗的艾滋病毒感染者人数。本研究旨在评估这一时期布基纳法索抗逆转录病毒治疗的状况。方法:在全国13个地区之一的中部高原地区进行回顾性描述性研究。我们从药品调剂数据库中提取了2018年至2023年的年度数据,该数据库用于监测接受抗逆转录病毒治疗的个体。我们分析了治疗开始的趋势。定量变量用中位数和四分位数范围来描述,定性变量用比例来描述。结果:从2018年到2023年,每年开始治疗的人数与检测阳性人数的比例从25%上升到100%。在这一时期的成年人中,超过70%是女性。治疗开始时的中位年龄为35岁(28-44岁)至32岁(25-44岁)。中位治疗时间为5年[2-8]至6年[3-12]。获得至少95%抗逆转录病毒药物分配覆盖率的成年人比例有所波动,从2020年的最高70%到2023年的最低47%不等。成人使用的主要治疗组合是TDF/FTC/EFV, 2018年占42%,2019年占50%,2020年占38%。TDF/3TC/EFV组合在2021年占主导地位,占46%。在2022年和2023年,TDF/3TC/DTG组合是最常见的,在2022年和2023年分别为76%和91%。从2019年到2022年,在儿童中,男性占主导地位(约55%)。开始治疗时的中位年龄为2岁[0-9]~ 4岁[2-9],中位治疗时间为5年[2-8]~ 6年[3-12]。2018 - 2021年AZT/3TC/NVP占主导地位(57%、59%、40%和40%),2022年ABC/3TC/DTG占主导地位(52%和84%)。从2018年到2023年,获得至少95%抗逆转录病毒药物分配覆盖率的儿童比例波动,从2019年的最高76%到2023年的最低24%不等。结论:自世卫组织提出“检测和治疗”建议以来,接受抗逆转录病毒治疗的人数比例逐渐增加。这些成果使布基纳法索更接近于实现联合国艾滋病规划署的目标。
{"title":"[Current status of antiretroviral treatment for people living with human immunodeficiency virus in Burkina Faso in the era of the World Health Organization's \"test and treat\" strategy].","authors":"Wedminère Noélie Zoungrana-Yameogo, Christian Yonli, Toussaint Compaore, Fidèle Bakiono, Arielle Rita Belem, Luc Delma, Abdoulaye So, Ouo Mireille Coulibaly, Koiné Maxime Drabo","doi":"10.48327/mtsi.v5i2.2025.631","DOIUrl":"10.48327/mtsi.v5i2.2025.631","url":null,"abstract":"<p><strong>Introduction: </strong>The World Health Organization's (WHO) \"test and treat\" strategy has significantly increased the number of people living with HIV (PLHIV) who receive antiretroviral therapy (ART). This study aimed to evaluate the status of ART in Burkina Faso during this period.</p><p><strong>Methods: </strong>A retrospective descriptive study was conducted in Plateau-Central, one of the country's 13 regions. We extracted annual data from 2018 to 2023 from the pharmaceutical dispensing database, which is used to monitor individuals receiving ART. We analyzed a trend in treatment initiation. Quantitative variables were described using the median and interquartile range, and qualitative variables were described using proportions.</p><p><strong>Results: </strong>From 2018 to 2023, the proportion of people who started treatment each year compared to the number of people who tested positive increased from 25% to 100%. Among adults during this period, more than 70% were women. The median age at the start of treatment ranged from 35 years (28-44) to 32 years (25-44). The median treatment duration ranged from five years [2-8] to six years [3-12]. The proportion of adults with at least 95% ART dispensing coverage fluctuated, ranging from a maximum of 70% in 2020 to a minimum of 47% in 2023. The main treatment combination used in adults was TDF/FTC/EFV, accounting for 42% in 2018, 50% in 2019, and 38% in 2020. The TDF/3TC/EFV combination was dominant in 2021, accounting for 46%. In 2022 and 2023, the TDF/3TC/DTG combination was the most common, at 76% in 2022 and 91% in 2023. Among children, males were predominant (around 55%) from 2019 to 2022. The median age at treatmentinitiation ranged from two years [0-9] to four years [2-9], and the median treatment duration ranged from five years [2-8] to six years [3-12]. AZT/3TC/NVP was predominant from 2018 to 2021 (57%, 59%, 40%, and 40%), and ABC/3TC/DTG was predominant from 2022 (52% and 84%). From 2018 to 2023, the proportion of children with at least 95% ART dispensing coverage fluctuated, ranging from a maximum of 76% in 2019 to a minimum of 24% in 2023.</p><p><strong>Conclusion: </strong>The proportion of people on ART has gradually increased since the WHO's \"test and treat\" recommendations. These results bring Burkina Faso closer to achieving the UNAIDS targets.</p>","PeriodicalId":101416,"journal":{"name":"Medecine tropicale et sante internationale","volume":"5 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12305227/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144755594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Antisynthetase syndrome: seven observations from the internal medicine department of the Libreville University Hospital, Gabon]. [反合成酶综合征:来自加蓬利伯维尔大学医院内科的7项观察]。
Pub Date : 2025-06-25 DOI: 10.48327/mtsi.v5i2.2025.711
Josaphat Iba Ba, Annick Mfoumou, Ingrid Nseng-Nseng Ondo, Ulrich Davy Kombila, Jean-Bruno Boguikouma

Introduction: Antisynthetases syndrome (AS) is a subgroup of inflammatory myopathy where myositis is associated to polyarthritis, interstitial pneumopathy, Raynaud's phenomenon, "mechanic's hands" skin lesions, and positive anti-aminoacyl-transfer RNA (tRNA) synthetase antibodies. Here, we present seven cases from Gabon.

Materials and methods: This retrospective descriptive study was conducted in the Internal Medicine Department at Libreville University Hospital from January 1, 1984, to December 31, 2023. The study aimed to identify all patients with documented AS and clarify its characteristics.

Results: Seven female patients with a mean age of 42.5 years were identified. The cardinal signs of AS were predominantly muscular (n = 7) and pulmonary (n = 5) with diffuse interstitial pneumopathy (n = 5). The patients experienced stage 2 (n = 3) to stage 3 (n = 2) dyspnea and cutaneous manifestations, including "mechanic's hands" (n = 4). Two patients were positive for Jo-1 antibodies, one for PL7 antibodies, and four for PL12 antibodies.

Discussion: AS poses a significant challenge to clinicians in sub-Saharan Africa due to the diffuse interstitial pneumonitis that accompanies pulmonary involvement.

Conclusion: Our study confirms the predominance of anti-PL12 antibodies and the late diagnosis of this condition.

简介:抗合成酶综合征(AS)是炎性肌病的一个亚群,其中肌炎与多发性关节炎、间质性肺炎、雷诺现象、“机械师之手”皮肤病变和抗氨基酰基转移RNA (tRNA)合成酶抗体阳性有关。在这里,我们介绍来自加蓬的七个病例。材料和方法:本回顾性描述性研究于1984年1月1日至2023年12月31日在利伯维尔大学医院内科进行。该研究旨在确定所有有AS记录的患者并阐明其特征。结果:7例女性患者,平均年龄42.5岁。AS的主要征象主要是肌肉(n = 7)和肺部(n = 5),并伴有弥漫性间质性肺病(n = 5)。患者经历第2期(n = 3)至第3期(n = 2)呼吸困难和皮肤表现,包括“机械师的手”(n = 4)。2例患者Jo-1抗体阳性,1例患者PL7抗体阳性,4例患者PL12抗体阳性。讨论:由于弥漫性间质性肺炎伴肺受累,AS对撒哈拉以南非洲的临床医生提出了重大挑战。结论:我们的研究证实了抗pl12抗体的优势和这种疾病的晚期诊断。
{"title":"[Antisynthetase syndrome: seven observations from the internal medicine department of the Libreville University Hospital, Gabon].","authors":"Josaphat Iba Ba, Annick Mfoumou, Ingrid Nseng-Nseng Ondo, Ulrich Davy Kombila, Jean-Bruno Boguikouma","doi":"10.48327/mtsi.v5i2.2025.711","DOIUrl":"10.48327/mtsi.v5i2.2025.711","url":null,"abstract":"<p><strong>Introduction: </strong>Antisynthetases syndrome (AS) is a subgroup of inflammatory myopathy where myositis is associated to polyarthritis, interstitial pneumopathy, Raynaud's phenomenon, \"mechanic's hands\" skin lesions, and positive anti-aminoacyl-transfer RNA (tRNA) synthetase antibodies. Here, we present seven cases from Gabon.</p><p><strong>Materials and methods: </strong>This retrospective descriptive study was conducted in the Internal Medicine Department at Libreville University Hospital from January 1, 1984, to December 31, 2023. The study aimed to identify all patients with documented AS and clarify its characteristics.</p><p><strong>Results: </strong>Seven female patients with a mean age of 42.5 years were identified. The cardinal signs of AS were predominantly muscular (n = 7) and pulmonary (n = 5) with diffuse interstitial pneumopathy (n = 5). The patients experienced stage 2 (n = 3) to stage 3 (n = 2) dyspnea and cutaneous manifestations, including \"mechanic's hands\" (n = 4). Two patients were positive for Jo-1 antibodies, one for PL7 antibodies, and four for PL12 antibodies.</p><p><strong>Discussion: </strong>AS poses a significant challenge to clinicians in sub-Saharan Africa due to the diffuse interstitial pneumonitis that accompanies pulmonary involvement.</p><p><strong>Conclusion: </strong>Our study confirms the predominance of anti-PL12 antibodies and the late diagnosis of this condition.</p>","PeriodicalId":101416,"journal":{"name":"Medecine tropicale et sante internationale","volume":"5 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12305228/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144755593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Status of COVID-19 vaccination among staff at the Tengandogo University Hospital Center, Ouagadougou, Burkina Faso, June to December 2021]. [2021年6月至12月布基纳法索瓦加杜古滕甘多戈大学医院中心工作人员COVID-19疫苗接种情况]。
Pub Date : 2025-06-03 eCollection Date: 2025-06-30 DOI: 10.48327/mtsi.v5i2.2025.625
Wedminère Noélie Zoungrana-Yameogo, David Kangoye, Issa Ouedraogo, Yassia Bamogo, Abdoulaye So, Arielle Rita Belem, Alban Michel Bassole, Idrissa Sanou

Introduction: According to the WHO, 278 million confirmed cases of COVID-19 had been recorded worldwide by the end of 2021, resulting in approximately 5.4 million deaths. In Burkina Faso, 17,632 cases and 318 deaths were recorded. Vaccination is one of the strategies implemented to control the pandemic. This study aimed to evaluate the status of the COVID-19 vaccination program among staff at a referral hospital in Burkina Faso.

Methods: From June 2 to December 31, 2021, we conducted a descriptive study at Tengandogo University Hospital (CHU-T). The study involved all staff members. Information was obtained through face-to-face and telephone interviews and self-administered questionnaires. Quantitative variables were described using the mean and standard deviation, while qualitative variables were described using proportions. All vaccinated individuals responded to the questionnaire. Unvaccinated individuals were volunteers.

Results: A total of 31% (174 out of 559) of healthcare workers were vaccinated, with a mean age of 41 ± 8 years. Men accounted for 55% (94/174) of the vaccinated workers. The main worker profiles were 62 doctors (35.6%), 62 nurses (35.6%), and nine ward boys and girls (5.2%). The main reason for accepting the vaccine was protection against the disease, reported by 132 workers (76%). There were 134 unvaccinated subjects who agreed to participate in the study. Their average age was 32.8 ± 7.3 years. The proportion of women was 60%. Uncertainty about vaccine effectiveness was the main reason for not getting vaccinated, cited by 106 workers (79%). Minor adverse events were reported by 136 of the vaccinated workers (78%). No serious adverse events were reported. Four vaccinated workers developed symptomatic SARS-CoV-2 infection during the study period.

Conclusion: The proportion of vaccinated subjects was low. Interventions to improve healthcare workers' adherence to vaccination should be developed.

导言:根据世卫组织的数据,截至2021年底,全球共记录了2.78亿例COVID-19确诊病例,导致约540万人死亡。在布基纳法索,记录了17 632例病例和318例死亡。疫苗接种是为控制大流行而实施的战略之一。本研究旨在评估布基纳法索一家转诊医院工作人员COVID-19疫苗接种计划的现状。方法:我们于2021年6月2日至12月31日在Tengandogo大学附属医院(CHU-T)进行描述性研究。这项研究涉及所有工作人员。信息是通过面对面和电话访谈以及自我填写的问卷获得的。定量变量用均值和标准差来描述,而定性变量用比例来描述。所有接种疫苗的人都回答了问卷。未接种疫苗的人是志愿者。结果:559名卫生工作者中有174人(31%)接种了疫苗,平均年龄为41±8岁。接种疫苗的工人中男性占55%(94/174)。主要工作人员为医生62人(35.6%)、护士62人(35.6%)、病区男女9人(5.2%)。132名工人(76%)报告说,接受疫苗的主要原因是预防疾病。有134名未接种疫苗的受试者同意参加这项研究。平均年龄32.8±7.3岁。女性的比例为60%。106名工人(79%)表示,不确定疫苗有效性是不接种疫苗的主要原因。接种疫苗的工作人员中有136人(78%)报告了轻微不良事件。无严重不良事件报告。在研究期间,四名接种疫苗的工人出现了症状性SARS-CoV-2感染。结论:接种人群比例偏低。应制定干预措施,提高卫生保健工作者对疫苗接种的依从性。
{"title":"[Status of COVID-19 vaccination among staff at the Tengandogo University Hospital Center, Ouagadougou, Burkina Faso, June to December 2021].","authors":"Wedminère Noélie Zoungrana-Yameogo, David Kangoye, Issa Ouedraogo, Yassia Bamogo, Abdoulaye So, Arielle Rita Belem, Alban Michel Bassole, Idrissa Sanou","doi":"10.48327/mtsi.v5i2.2025.625","DOIUrl":"10.48327/mtsi.v5i2.2025.625","url":null,"abstract":"<p><strong>Introduction: </strong>According to the WHO, 278 million confirmed cases of COVID-19 had been recorded worldwide by the end of 2021, resulting in approximately 5.4 million deaths. In Burkina Faso, 17,632 cases and 318 deaths were recorded. Vaccination is one of the strategies implemented to control the pandemic. This study aimed to evaluate the status of the COVID-19 vaccination program among staff at a referral hospital in Burkina Faso.</p><p><strong>Methods: </strong>From June 2 to December 31, 2021, we conducted a descriptive study at Tengandogo University Hospital (CHU-T). The study involved all staff members. Information was obtained through face-to-face and telephone interviews and self-administered questionnaires. Quantitative variables were described using the mean and standard deviation, while qualitative variables were described using proportions. All vaccinated individuals responded to the questionnaire. Unvaccinated individuals were volunteers.</p><p><strong>Results: </strong>A total of 31% (174 out of 559) of healthcare workers were vaccinated, with a mean age of 41 ± 8 years. Men accounted for 55% (94/174) of the vaccinated workers. The main worker profiles were 62 doctors (35.6%), 62 nurses (35.6%), and nine ward boys and girls (5.2%). The main reason for accepting the vaccine was protection against the disease, reported by 132 workers (76%). There were 134 unvaccinated subjects who agreed to participate in the study. Their average age was 32.8 ± 7.3 years. The proportion of women was 60%. Uncertainty about vaccine effectiveness was the main reason for not getting vaccinated, cited by 106 workers (79%). Minor adverse events were reported by 136 of the vaccinated workers (78%). No serious adverse events were reported. Four vaccinated workers developed symptomatic SARS-CoV-2 infection during the study period.</p><p><strong>Conclusion: </strong>The proportion of vaccinated subjects was low. Interventions to improve healthcare workers' adherence to vaccination should be developed.</p>","PeriodicalId":101416,"journal":{"name":"Medecine tropicale et sante internationale","volume":"5 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12308574/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144762904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Knowledge and perceptions of people living with HIV regarding adherence support mechanisms in treatment centers in the Plateau-Central region of Burkina Faso, November 2024]. [2024年11月,布基纳法索高原-中部地区治疗中心艾滋病毒感染者关于依从性支持机制的知识和看法]。
Pub Date : 2025-05-12 eCollection Date: 2025-06-30 DOI: 10.48327/mtsi.v5i2.2025.643
Wedminère Noélie Zoungrana-Yameogo, Dominique Hélène Laurel Yabre, Fidèle Bakiono, Toussaint Compaore, Arielle Rita Belem, David Kangoye, Christian Philippe Yonli, Ouo Mireille Coulibaly, Koiné Maxime Drabo

Introduction: Since the introduction of antiretroviral therapy for HIV in Burkina Faso, several treatment adherence support mechanisms have been implemented to improve outcomes and prevent resistance. Our study aimed to evaluate the knowledge and perceptions of people living with HIV (PLHIV) regarding these mechanisms in the Plateau-Central region.

Methods: We conducted a descriptive study in the Plateau-Central region, which is one of the 13 regions of Burkina Faso. PLHIV were selected as they arrived for their follow-up visits. Information was collected through interviews using a standardized questionnaire. Adherence was calculated based on the participants' reports. Those who took all their medications in the month prior to the survey were considered adherent. Quantitative variables were calculated using the averages, and qualitative variables were calculated using proportions.

Results: A total of 347 PLHIV were included in the study. Of these, 69% were women, with a mean age of 45.6 ± 12.2 years. The mean treatment follow-up duration was 8.6 ± 5 years. Eighty percent of individuals adhered to treatment (95% CI [75-84]). Nearly all PLHIV (99.7%) were aware of adherence support mechanisms. The most well-known mechanisms were six-month antiretroviral drug supplies (RAVI6M) (71%), discussion groups (69.9%), individual discussion (69.9%), and counseling (64.2%).The recently introduced community-based antiretroviral drug refilling program outside of health facilities was less well known (42.2%). The most commonly used measures were face-to-face discussion (64%), counseling (62%), and RAVI6M (61.7%). The most appreciated measures were the six-month supply of antiretroviral drugs (44.6%), drug counting (10.7%), and patient interview (10.1%).

Conclusion: PLHIV are familiar with and appreciate adherence support measures. The most appreciated measure is six-monthly refills of ARV drugs. Community-based ARV supply policies should be encouraged.

导论:自布基纳法索采用抗逆转录病毒治疗艾滋病毒以来,已经实施了若干治疗依从性支持机制,以改善结果并预防耐药性。我们的研究旨在评估高原-中部地区艾滋病毒感染者(PLHIV)对这些机制的认识和看法。方法:我们在布基纳法索13个地区之一的高原-中部地区进行了描述性研究。在他们到达时被选中进行随访。通过使用标准化问卷的访谈收集信息。依从性是根据参与者的报告来计算的。那些在调查前一个月服用了所有药物的人被认为是坚持服用的。定量变量用平均值计算,定性变量用比例计算。结果:共纳入347例PLHIV。其中69%为女性,平均年龄为45.6±12.2岁。平均治疗随访时间8.6±5年。80%的个体坚持治疗(95% CI[75-84])。几乎所有的hiv感染者(99.7%)都知道依从性支持机制。最著名的机制是六个月抗逆转录病毒药物供应(RAVI6M)(71%)、小组讨论(69.9%)、个人讨论(69.9%)和咨询(64.2%)。最近在卫生设施之外实施的以社区为基础的抗逆转录病毒药物补充规划鲜为人知(42.2%)。最常用的措施是面对面讨论(64%)、咨询(62%)和RAVI6M(61.7%)。最受欢迎的措施是6个月抗逆转录病毒药物供应(44.6%)、药物计数(10.7%)和患者面谈(10.1%)。结论:hiv感染者对支持措施的依从性较为熟悉和满意。最受欢迎的措施是每六个月补充一次抗逆转录病毒药物。应鼓励以社区为基础的抗逆转录病毒药物供应政策。
{"title":"[Knowledge and perceptions of people living with HIV regarding adherence support mechanisms in treatment centers in the Plateau-Central region of Burkina Faso, November 2024].","authors":"Wedminère Noélie Zoungrana-Yameogo, Dominique Hélène Laurel Yabre, Fidèle Bakiono, Toussaint Compaore, Arielle Rita Belem, David Kangoye, Christian Philippe Yonli, Ouo Mireille Coulibaly, Koiné Maxime Drabo","doi":"10.48327/mtsi.v5i2.2025.643","DOIUrl":"10.48327/mtsi.v5i2.2025.643","url":null,"abstract":"<p><strong>Introduction: </strong>Since the introduction of antiretroviral therapy for HIV in Burkina Faso, several treatment adherence support mechanisms have been implemented to improve outcomes and prevent resistance. Our study aimed to evaluate the knowledge and perceptions of people living with HIV (PLHIV) regarding these mechanisms in the Plateau-Central region.</p><p><strong>Methods: </strong>We conducted a descriptive study in the Plateau-Central region, which is one of the 13 regions of Burkina Faso. PLHIV were selected as they arrived for their follow-up visits. Information was collected through interviews using a standardized questionnaire. Adherence was calculated based on the participants' reports. Those who took all their medications in the month prior to the survey were considered adherent. Quantitative variables were calculated using the averages, and qualitative variables were calculated using proportions.</p><p><strong>Results: </strong>A total of 347 PLHIV were included in the study. Of these, 69% were women, with a mean age of 45.6 ± 12.2 years. The mean treatment follow-up duration was 8.6 ± 5 years. Eighty percent of individuals adhered to treatment (95% CI [75-84]). Nearly all PLHIV (99.7%) were aware of adherence support mechanisms. The most well-known mechanisms were six-month antiretroviral drug supplies (RAVI6M) (71%), discussion groups (69.9%), individual discussion (69.9%), and counseling (64.2%).The recently introduced community-based antiretroviral drug refilling program outside of health facilities was less well known (42.2%). The most commonly used measures were face-to-face discussion (64%), counseling (62%), and RAVI6M (61.7%). The most appreciated measures were the six-month supply of antiretroviral drugs (44.6%), drug counting (10.7%), and patient interview (10.1%).</p><p><strong>Conclusion: </strong>PLHIV are familiar with and appreciate adherence support measures. The most appreciated measure is six-monthly refills of ARV drugs. Community-based ARV supply policies should be encouraged.</p>","PeriodicalId":101416,"journal":{"name":"Medecine tropicale et sante internationale","volume":"5 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12308576/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144762903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[XXIXth Actualités du Pharo. Sport and health in tropical environments - Repercussions of crises (health, climate, social, security) on the health of tropical populations. October 2-4, 2024, Marseille, France]. 第二十九法罗的实际情况[j]热带环境中的体育与健康——危机(健康、气候、社会、安全)对热带人口健康的影响。2024年10月2日至4日,法国马赛。
Pub Date : 2025-04-03 eCollection Date: 2025-06-30 DOI: 10.48327/mtsi.v5i2.2025.669
Jean-Paul Boutin
{"title":"[XXIX<sup>th</sup> Actualités du Pharo. Sport and health in tropical environments - Repercussions of crises (health, climate, social, security) on the health of tropical populations. October 2-4, 2024, Marseille, France].","authors":"Jean-Paul Boutin","doi":"10.48327/mtsi.v5i2.2025.669","DOIUrl":"https://doi.org/10.48327/mtsi.v5i2.2025.669","url":null,"abstract":"","PeriodicalId":101416,"journal":{"name":"Medecine tropicale et sante internationale","volume":"5 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12308577/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144762905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medecine tropicale et sante internationale
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1